Clinical Trial Update: Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer

View source ↗

Summary

This entry notes a real-world study of toripalimab for extensive-stage small cell lung cancer, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Fudan University | Conditions: SCLC, Extensive Stage, Toripalimab | Status: NOT_YET_RECRUITING